JP2023501352A5 - - Google Patents

Info

Publication number
JP2023501352A5
JP2023501352A5 JP2022526072A JP2022526072A JP2023501352A5 JP 2023501352 A5 JP2023501352 A5 JP 2023501352A5 JP 2022526072 A JP2022526072 A JP 2022526072A JP 2022526072 A JP2022526072 A JP 2022526072A JP 2023501352 A5 JP2023501352 A5 JP 2023501352A5
Authority
JP
Japan
Prior art keywords
nucleic acid
sequence
modified
modified oligonucleotide
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022526072A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023501352A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/059506 external-priority patent/WO2021092459A1/en
Publication of JP2023501352A publication Critical patent/JP2023501352A/ja
Publication of JP2023501352A5 publication Critical patent/JP2023501352A5/ja
Priority to JP2026027370A priority Critical patent/JP2026094239A/ja
Pending legal-status Critical Current

Links

JP2022526072A 2019-11-08 2020-11-06 Spdef発現を低減するための化合物及び方法 Pending JP2023501352A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026027370A JP2026094239A (ja) 2019-11-08 2026-02-24 Spdef発現を低減するための化合物及び方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962932758P 2019-11-08 2019-11-08
US62/932,758 2019-11-08
US202063056969P 2020-07-27 2020-07-27
US63/056,969 2020-07-27
PCT/US2020/059506 WO2021092459A1 (en) 2019-11-08 2020-11-06 Compounds and methods for reducing spdef expression

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026027370A Division JP2026094239A (ja) 2019-11-08 2026-02-24 Spdef発現を低減するための化合物及び方法

Publications (2)

Publication Number Publication Date
JP2023501352A JP2023501352A (ja) 2023-01-18
JP2023501352A5 true JP2023501352A5 (cg-RX-API-DMAC7.html) 2023-11-14

Family

ID=75849553

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022526072A Pending JP2023501352A (ja) 2019-11-08 2020-11-06 Spdef発現を低減するための化合物及び方法
JP2026027370A Pending JP2026094239A (ja) 2019-11-08 2026-02-24 Spdef発現を低減するための化合物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026027370A Pending JP2026094239A (ja) 2019-11-08 2026-02-24 Spdef発現を低減するための化合物及び方法

Country Status (5)

Country Link
US (2) US20210139906A1 (cg-RX-API-DMAC7.html)
EP (1) EP4054655A4 (cg-RX-API-DMAC7.html)
JP (2) JP2023501352A (cg-RX-API-DMAC7.html)
TW (1) TW202128999A (cg-RX-API-DMAC7.html)
WO (1) WO2021092459A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021258011A1 (en) * 2020-06-19 2021-12-23 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating pmp22

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010010934A1 (en) * 1998-07-31 2001-08-02 Towia Aron Libermann Prostate derived ets factor
US6821724B1 (en) * 1998-09-17 2004-11-23 Affymetrix, Inc. Methods of genetic analysis using nucleic acid arrays
EP2305813A3 (en) * 2002-11-14 2012-03-28 Dharmacon, Inc. Fuctional and hyperfunctional sirna
US20060257851A1 (en) * 2002-11-26 2006-11-16 Itzhak Bentwich Bioinformatically detectable group of novel viral regulatory genes and uses thereof
US20070009899A1 (en) * 2003-10-02 2007-01-11 Mounts William M Nucleic acid arrays for detecting gene expression in animal models of inflammatory diseases
US20050244851A1 (en) * 2004-01-13 2005-11-03 Affymetrix, Inc. Methods of analysis of alternative splicing in human
US20050221354A1 (en) * 2004-02-18 2005-10-06 Wyeth Nucleic acid arrays for monitoring expression profiles of drug target genes
US20070048756A1 (en) * 2005-04-18 2007-03-01 Affymetrix, Inc. Methods for whole genome association studies
AU2007225238A1 (en) * 2006-03-10 2007-09-20 Wyeth Microarray for monitoring gene expression in multiple strains of Streptococcus pneumoniae
US20090123928A1 (en) * 2007-10-11 2009-05-14 The Johns Hopkins University Genomic Landscapes of Human Breast and Colorectal Cancers
EP2220230A2 (en) * 2007-11-09 2010-08-25 Isis Pharmaceuticals, Inc. Modulation of factor 9 expression
US8257716B2 (en) * 2007-12-21 2012-09-04 Ashwani Sood Anti-PDEF antibodies and uses thereof
WO2010115278A1 (en) * 2009-04-06 2010-10-14 University Of Saskatchewan Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
US20120053112A1 (en) * 2009-05-05 2012-03-01 Children's Hospital Medical Center Methods and compositions related to the regulation of goblet cell differentiation, mucus production and mucus secretion
JP2014501489A (ja) * 2009-07-06 2014-01-23 アルナイラム ファーマシューティカルズ, インコーポレイテッド 細胞ベースのバイオプロセシング
US9920317B2 (en) * 2010-11-12 2018-03-20 The General Hospital Corporation Polycomb-associated non-coding RNAs
EP3702460A1 (en) * 2010-11-12 2020-09-02 The General Hospital Corporation Polycomb-associated non-coding rnas
US9175291B2 (en) * 2012-10-11 2015-11-03 Isis Pharmaceuticals Inc. Modulation of androgen receptor expression
EP3027753B1 (en) * 2013-07-29 2018-09-12 Universität zu Köln Neurocalcin delta inhibitors and therapeutic and non-therapeutic uses thereof
EP3169776B1 (en) * 2014-07-14 2025-09-03 The Regents of The University of California Crispr/cas transcriptional modulation
EP3286318A2 (en) * 2015-04-22 2018-02-28 Mina Therapeutics Limited Sarna compositions and methods of use
US20170343551A1 (en) * 2016-04-05 2017-11-30 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method of diagnosing and treating prostate cancer
TWI840345B (zh) * 2018-03-02 2024-05-01 美商Ionis製藥公司 Irf4表現之調節劑

Similar Documents

Publication Publication Date Title
JP2021530204A5 (cg-RX-API-DMAC7.html)
JP2022527105A5 (cg-RX-API-DMAC7.html)
JP2022515193A5 (cg-RX-API-DMAC7.html)
TW202208625A (zh) 經修飾之短干擾核酸(siNA)分子及其用途
JP2023536974A5 (cg-RX-API-DMAC7.html)
JP2022518929A5 (cg-RX-API-DMAC7.html)
JP2022520986A5 (cg-RX-API-DMAC7.html)
JP2023537798A5 (cg-RX-API-DMAC7.html)
JP2022533358A5 (cg-RX-API-DMAC7.html)
JP2021526823A5 (cg-RX-API-DMAC7.html)
JP2023536472A5 (cg-RX-API-DMAC7.html)
TW202113079A (zh) 經修飾之間隙子寡核苷酸及其使用方法
JP2021522800A5 (cg-RX-API-DMAC7.html)
JP2019525918A5 (cg-RX-API-DMAC7.html)
JP2024516096A5 (cg-RX-API-DMAC7.html)
JP2021511072A5 (cg-RX-API-DMAC7.html)
JP2024516356A5 (cg-RX-API-DMAC7.html)
KR20200104347A (ko) 포스포로디티오에이트 인터뉴클레오시드 연결을 포함하는 갭머 올리고뉴클레오티드
JP2010500291A5 (cg-RX-API-DMAC7.html)
JP2021515784A5 (cg-RX-API-DMAC7.html)
JP2023549563A5 (cg-RX-API-DMAC7.html)
CN114828859A (zh) siRNA缀合物、双链siRNA缀合物及其盐和应用
ES2301659T3 (es) Metodos para aumentar la eficacia in vivo de oligonucleotidos e inhibir la inflamacion en mamiferos.
JP2025511183A5 (cg-RX-API-DMAC7.html)
JP2022552192A (ja) レチノイン酸誘導遺伝子iタンパク質に結合する核酸化合物